Form 4: Beauty Health Co Chairman Brent Saunders Granted Over 73,000 Restricted Stock Units

Brent L. Saunders, Chairman and Director of The Beauty Health Company, was granted 73,051 restricted stock units, increasing his beneficial ownership.

Summary

• Brent L. Saunders, Chairman and Director of The Beauty Health Company (SKIN), was granted 73,051 Class A Common Stock restricted stock units (RSUs) on June 16, 2025.
• The RSUs are contingent on Mr. Saunders' continued service as a board member and will vest on the earlier of the one-year anniversary of the grant (June 16, 2026) or the date of the 2026 Annual Meeting of Stockholders.
• Following this transaction, Mr. Saunders' direct beneficial ownership of Class A Common Stock is 5,994,820 shares.
• Additionally, he indirectly beneficially owns 1,681,771 shares through Triplet Enterprises III, LLC and 1,121,180 shares through the Saunders Family Trust, though he disclaims beneficial ownership except for any pecuniary interest.

Sentiment

Score: 7

Explanation: The grant of restricted stock units to a key director and chairman is generally a positive signal, indicating continued alignment of interests and retention of leadership. While it represents a future potential dilution, it's a standard compensation practice.

Positives

• The grant of 73,051 restricted stock units to Chairman Brent L. Saunders aligns his interests with long-term shareholder value, as vesting is contingent on his continued service.
• The transaction demonstrates ongoing commitment and compensation for a key executive and director.

Negatives

• The grant of restricted stock units could lead to minor dilution for existing shareholders upon vesting, though this is a standard form of executive compensation.

Future Outlook

The document does not provide forward-looking statements or guidance beyond the vesting schedule of the granted restricted stock units.

Industry Context

This Form 4 filing is a routine disclosure of an insider equity grant, common across all industries as a form of executive and director compensation. It does not provide specific insights into broader industry trends within the beauty and health sector.

Comparison to Industry Standards

• The grant of restricted stock units to a director is a standard practice for executive and board compensation across publicly traded companies.
• The specific amount and vesting schedule would typically be benchmarked against peer companies in the beauty and health industry, but this document does not provide the necessary data for such a detailed comparison (e.g., compensation committee rationale, peer group analysis).

Corporate Governance

Related Party Transactions

• The grant of restricted stock units to Brent L. Saunders, a Director and Chairman, constitutes a related party transaction as it involves compensation from the company to a key insider.

Stakeholder Impact

• Shareholders: Potential for minor dilution upon vesting of RSUs, but also increased alignment of a key director's interests with long-term shareholder value.

Next Steps

• The granted restricted stock units are expected to vest on the earlier of June 16, 2026, or the date of the 2026 Annual Meeting of Stockholders, contingent on Brent L. Saunders' continued service.

Key Dates

Keywords

Beauty Health Co, SKIN, Brent L. Saunders, Restricted Stock Units, RSU Grant, Insider Transaction, SEC Form 4, Director Compensation, Equity Compensation, Beneficial Ownership